脑部放疗，上午比下午敏感许多！
6 t- X; ~- q$ L0 k! @" q% w3 D, s& s0 d3 ]$ S+ [
0 ~, D' E- ]9 q# t* S7 x
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
2 S! V+ B, [( d% ?Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?' B9 U) h2 @# U3 J
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
4 V N6 Z$ i# wSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.+ i3 f! F" X/ `) u: p; u
3 z5 F" p7 [6 |" j/ d2 l
Abstract
7 u+ a8 m& l: C6 vBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
5 q6 N; V1 ^5 R9 T: a2 s$ k' M5 h. S z4 ~8 S& r3 R" h, s- s$ }- {& d
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.# Z3 ~5 {% v5 S+ U0 C
2 B" R# q+ a% E* DRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).( w! Z( c0 l0 [" L
: O' d1 |# g6 F0 q, c2 U. l
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.3 x8 o- c: v/ }$ ^# H" j
4 }7 q; Z; F" H6 W8 ]" D/ y |
显身卡
% L' H k. \) R; d4 @1 V
